Non convulsive status epilepticus after replacement of valproate with lamotrigine

Journal of Neurology

Volumn 249, Issue 10, 2002, Pages 1417-1422

  Trinka, Eugen ^a   Dilitz, Erika ^a   Unterberger, Iris ^a   Luef, Gerhard ^a   Deisenhammer, Florian ^a   Niedermüller, Ulrike ^a   Thaler, Claudia ^a   Bauer, Gerhard ^a  

^a Universitatsklinik fur Neurochirurgie Innsbruck   (Austria)

Author keywords

Antiepileptic drugs; Drug induced seizures; Lamotrigine; Seizure aggravation; Status epilepticus

Indexed keywords

BENZODIAZEPINE DERIVATIVE; DIAZEPAM; LAMOTRIGINE; LORAZEPAM; VALPROIC ACID;

ADULT; AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONFUSION; CONTROLLED STUDY; DISEASE COURSE; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAM; EPILEPTIC STATE; FEMALE; HUMAN; MYOCLONUS; PRIORITY JOURNAL; SPIKE WAVE; SYMPTOM;

ADULT; AGED; ANTICOAGULANTS; BENZODIAZEPINES; ELECTROENCEPHALOGRAPHY; EPILEPSY, GENERALIZED; FEMALE; HUMANS; MIDDLE AGED; RETROSPECTIVE STUDIES; STATUS EPILEPTICUS; SUBSTANCE WITHDRAWAL SYNDROME; TRIAZINES; VALPROIC ACID;

EID: 0036405462     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00415-002-0857-3     Document Type: Article

References (40)

1. Brodie MJ (1992) Lamotrigine. Lancet 339: 1397-1400
2. Pinder RM, Brodgen RM, Speight TM (1977) Sodium valproate: a review of its pharmacological properties and therapeutic efficacy in epilepsy. Drugs 13: 81-123
3. Sabers A and Gram L (2000) Newer anticonvulsants. Comparative review of drug interactions and adverse effects. Drugs 60: 23-33
4. Frank LM, Enlow T, Holmes GL, Manasco P, Concannon S, Chen C, Womble G, Casale EJ (1999) Lamictal (lamotrigine) monotherapy for typical absence seizures in children. Epilepsia 40: 973-979
5. Ferrie CD, Panayiotopoulos CP (1994) Therapeutic interaction of lamotrigine and sodium valproate in intractable myoclonic epilepsy. Seizure 3: 157-159
6. Buoni S, Grosso S, Fois A (1999) Lamotrigine in typical absence epilepsy. Brain Dev 21: 303-306
7. Gericke CA, Pickard F, de Saint-Martin A, Strumia S, Marescaux C, Hirsch E (1999) Efficacy of lamotrigine in idiopathic generalized epilepsy syndromes: a video-EEG-controlled, open study. Epileptic Disorders 1: 159-165
8. Buchanan N (1996) The use of lamotrigine in juvenile myoclonic epilepsy. Seizure 5: 149-151
9. Sander JW, Patsalos PN, Oxley JR, Hamilton MJ, Yuen WC (1990) A randomized placebo controlled add-on trial of lamotrigine in patients with severe epilepsy. Epilepsy Res 6: 221-226
10. Genton P, Dravet C, Bureau M, Belmonte A, Kaminska A, Dulac O. (1997) Aggravation of severe myoclonic epilepsy of infancy by lamotrigine. Epilepsia 38 (suppl. 3): S32
11. Guerrini R, Dravet C, Genton P, Belmonte A, Kaminska A, Dulac O (1998) Lamotrigine and seizure aggravation in severe myoclonic epilepsy. Epilepsia 39: 508-512
12. Guerrini R, Belmonte A, Genton P (1998) Antiepileptic drug-induced worsening of seizures in children. Epilepsia 39 (suppl. 3): S2-10
13. Guerrini R, Belmonte A, Parmeggiani L, Perucca E (1999) Myoclonic status epilepticus following high-dosage lamotrigine therapy. Brain Dev 21: 420-424
14. Janszky J, Rosalyn G, Halasz P, Olajos S, Prenyi J, Szucs A, Debreczeni T (2000) Disabling erratic myoclonus during lamotrigine therapy with high serum levels - report of two cases. Clin Neuropharmacol 23: 86-89
15. Oller-Daurella ML (1971) Critique du concept de l'épilepsie généralisée primaire, fondée sur la révision d'une série de cas personnels, dont le diagnostic clinique et E.E.G. semble indubitable. Rev Neurol (Paris) 124: 487-494
16. Bauer J (1996) Seizure-inducing effects of antiepileptic drugs: a review. Acta Neurol Scand 94: 367-377
17. Genton P (2000) When antiepileptic drugs aggravate epilepsy. Brain Dev 22: 75-80
18. Loiseau P (1997) Do antiepileptic drugs exacerbate seizures? Epilepsia 39: 2-4
19. Perucca E, Gram L, Avanzini G, Dulac O (1998) Antiepileptic drugs as a cause of worsening seizures. Epilepsia 39: 5-17
20. Marioni P, Galletti F, Brinciotti M, Pelliccia A (1987) Stato di male non-convulsivo in rapporto a intossicazione da fenobarbital. Minerva Pediatr 39: 865
21. Schapel G, Chadwick D (1996) Tiagabine and non-convulsive status epilepticus. Seizure 5: 153-156
22. Eckardt KM, Steinhoff BJ (1998) Non-convulsive status epilepticus in two patients receiving tiagabine treatment. Epilepsia 39: 671-674
23. Trinka E, Moroder T, Nagler M, Staffen W, Löscher WN, Ladurner G (1999) Clinical and EEG findings in complex partial status epilepticus with tiagabine. Seizure; 8: 41-44
24. Ettinger AB, Bernal OG, Andriola MR, Bagchi S, Flores P, Just C, Pitocco C, Rooney T, Tuominen J, Devinsky O (1999) Two cases of nonconvulsive status epilepticus in association with tiagabine therapy. Epilepsia 40: 1159-1162
25. Shields WD, Saslow E (1983) Myoclonic, atonic, and absence seizures following institution of carbamazepine therapy in children. Neurology 33: 1487-1489
26. Snead OC, Hosey LN (1985) Exacerbation of seizures in children by carbamazepine. N Engl J Med 313: 916-921
27. Johnsen SD, Tarby TJ, Sidell AD (1984) Carbamazepine induced seizures. Ann Neurol 16: 392-393
28. Lortie A, Chiron C, Dulac O (1993) The potential for increasing seizure frequency, relapse, and appearance of new seizure types with vigabatrin. Neurology 43 (suppl. 5): S24-27
29. Knake S, Hamer HM, Schomburg U, Oertel WH, Rosenow F (1999) Tiagabine-induced absence status in idiopathic generalized epilepsy. Seizure 5: 314-317
30. Catania S, Cross H, deSousa C, Boyd S (1999) Paradoxic reaction to lamotrigine in a child with benign focal epilepsy of childhood with centrotemporal spikes. Epilepsia 40: 1657-1660
31. Biraben A, Allain H, Scarabin JM, Schück S, Edan G (2000) Exacerbation of juvenile myoclonic epilepsy with lamotrigine. Neurology 55: 1758-1759
32. Pisani F, Russo M, Trio R, Artesi C, Fazio A, Oteri G, Di Perri R (1992) Efficacia dell'associazione lamotrigina-valproato di sodio nelle crisi epilettiche parziali resistenti. Q Acta Neurol 58: 71-73
33. Pisani F, Perucca E, Richens A Interaction of lamotrigine with sodium valproate (1993) Lancet 341: 1224
34. Ferrie CD, Robinson RO, Knott C, Panayiotopoulos CP (1995) Lamotrigine as add-on drug in typical absences. Acta Neurol Scand 91: 200-202
35. Panayiotopoulos CP, Ferrie CD, Knott C, Robinson RO (1993) Interaction of lamotrigine with sodium valproate. Lancet 341: 445
36. Veggiotti P, Cieuta C, Rex E, Dulac O (1994) Lamotrigine in infantile spasms. Lancet 344: 1375-1376
37. Pisani F, Oteri G, Russo MF, Di Perri R, Perucca E, Richens A (1999) The efficacy of valproate-lamotrigine comedication in refractory complex partial seizures: evidence for a pharmacodynamic interaction. Epilepsia 40: 1141-1146
38. Yuen AWC, Land G, Wetherly BC, Pech AW (1992) Sodium valproate acutely inhibits lamotrigine metabolism. Br J Clin Pharmacol 33: 511-513
39. Kilpatrick ES, Forrest G, Brodie MJ (1996) Concentration-effect and concentration-toxicity relations with lamotrigine, a prospective study. Epilepsia 37: 534-538
40. Federspiel-Simma S, Trinka E, Luef G, Niedermüller U, Unterberger I, Bauer G (2000) Non-convulsive status epilepticus after replacement of valproate with lamotrigine: a report of two patients. Epilepsia 41 (Suppl. Florence): S103